Story

thyssenkrupp nucera Stock Drops on Lowered Guidance, Scrapped SOEC Plans

ENTHMSVIIDZHZH-TWJAKOHI
Aug 12, 20262 min read
thyssenkrupp nucera Stock Drops on Lowered Guidance, Scrapped SOEC Plans
Text size
Background

Shares of thyssenkrupp nucera AG & Co. KGaA (ETR: NCH2) declined after the company announced it was abandoning a key technology program and simultaneously lowered its full-year earnings guidance. The dual negative catalysts overshadowed a stronger-than-expected quarterly sales report, prompting a reassessment of the company's growth trajectory by investors.

Strategic Pivot and Financial Impact

The company disclosed its decision to exit the mass production of Solid Oxide Electrolysis Cells (SOEC) following a strategic review. Citing market readiness, investment needs, and economic prospects, thyssenkrupp nucera will scrap the program.

This move is expected to result in one-off EBIT charges of approximately €30 million. According to the company, these charges are primarily from the impairment of a pilot plant and capitalized development costs associated with the SOEC technology.

Guidance Cut Overshadows Quarterly Beat

While the strategic shift weighed on sentiment, the primary driver for the stock's decline was a significant cut to its financial outlook, released alongside its Q3 fiscal 2025/26 earnings. The company slashed its full-year EBIT guidance to a range of -€155 million to -€135 million, a material deterioration from its previous forecast. A trimmed revenue forecast for its Green Hydrogen segment accompanied the lowered profit outlook.

Sample IUX Markets – In-articleAd

The negative guidance overshadowed otherwise resilient operational results for the quarter:

  • Q3 Sales: €145 million, beating analyst consensus of €112 million, driven by timing pull-forwards in its Chlor-Alkali business.
  • Order Intake: Grew 29% year-over-year.

Market Context

The stock's decline was company-specific, as Germany's broader DAX index remained stable. The news pushed the share price toward the lower end of its 52-week range, significantly below its annual high of €11.90. Peers in the green hydrogen sector have also faced headwinds from cautious capital spending by clients and slower project development, providing little support. For investors, the combination of a scrapped technology pillar and a weaker earnings outlook raises questions about the timeline for the Green Hydrogen segment to become a profitable contributor.

Read next

More on Stocks
Back to latest news

LATEST